The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer’s Disease and Other Dementias in the United States
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objectives: We assessed potential benefits for older Americans of reducing risk factors associated with dementia. Methods: A dynamic simulation model tracked a national cohort of persons 51 and 52 years of age to project dementia onset and mortality in risk reduction scenarios for diabetes, hypertension, and dementia. Results: We found reducing incidence of diabetes by 50% did not reduce number of years a person ages 51 or 52 lived with dementia and increased the population ages 65 and older in 2040 with dementia by about 115,000. Eliminating hypertension at middle and older ages increased life expectancy conditional on survival to age 65 by almost 1 year, however, it increased years living with dementia. Innovation in treatments that delay onset of dementia by 2 years increased longevity, reduced years with dementia, and decreased the population ages 65 and older in 2040 with dementia by 2.2 million. Conclusions: Prevention of chronic disease may generate health and longevity benefits but does not reduce burden of dementia. A focus on treatments that provide even short delays in onset of dementia can have immediate impacts on longevity and quality of life and reduce the number of Americans with dementia over the next decades.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
Cellular senescence: a translational perspective
Kirkland, J. L., & Tchkonia, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.013 · Cited by 1,013
Stevens, V. J., Obarzanek, E., Cook, N. R., Lee, I.-M., Appel, L. J., Smith West, D., Milas, N. C., Mattfeldt-Beman, M., Belden, L., Bragg, C., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-1-200101020-00007 · Cited by 886
Education at a Glance 2016: OECD Indicators
OECD (2016) · Education at a Glance · doi:10.1787/eag-2016-en · Cited by 430
The Value of Delaying Alzheimer’s Disease Onset
Zissimopoulos, J., Crimmins, E., & St.Clair, P. (2015) · Forum for Health Economics and Policy · doi:10.1515/fhep-2014-0013 · Cited by 267
Self-citationTom, S. E., Hubbard, R. A., Crane, P. K., Haneuse, S. J., Bowen, J., McCormick, W. C., McCurry, S., & Larson, E. B. (2015) · American Journal of Public Health · doi:10.2105/ajph.2014.301935 · Cited by 185
Research works printed but not linked: 26
- Barnes, 2011, The projected effect of risk factor reduction on Alzheimer’s disease prevalence, The Lancet Neurology, 10, 819, 10.1016/S1474-4422(11)70072-2 · DOI · Paper page
- Brookmeyer, 2011, National estimates of the prevalence of Alzheimer’s disease in the United States, Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7, 61, 10.1016/j.jalz.2010.11.007 · DOI · Paper page
- Crimmins, 2011, Assessment of cognition using surveys and neuropsychological assessment: The health and retirement study and the aging, demographics, and memory study, The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 66B, i162, 10.1093/geronb/gbr048 · DOI · Paper page
- Crimmins, 2016, Change in cognitively healthy and cognitively impaired life expectancy in the United States: 2000-2010, SSM - Population Health, 2, 793, 10.1016/j.ssmph.2016.10.007 · DOI · Paper page
- Crimmins, 2016, Trends over 4 decades in disability-free life expectancy in the United States, American Journal of Public Health, 106, 1287, 10.2105/AJPH.2016.303120 · DOI · Paper page
- Fratiglioni, 1999, Worldwide prevalence and incidence of dementia, Drugs & Aging, 15, 365, 10.2165/00002512-199915050-00004 · DOI · Paper page
- Fisher, 2013, Health and retirement study imputation of cognitive functioning measures 1992–2010, 231
- Fishman, 2017, Lifetime risk of dementia in the U.S, Demography, 54, 1897, 10.1007/s13524-017-0598-7 · DOI
- Freedman, 2004, Resolving inconsistencies in trends in old-age disability: Report from a technical working group, Demography, 41, 417, 10.1353/dem.2004.0022 · DOI · Paper page
- Goldin, 2007, Long-run changes in the wage structure: Narrowing, widening, polarizing, Brookings Papers on Economic Activity, 38, 135, 10.1353/eca.2008.0000 · DOI · Paper page
- Gu, 2014, Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003–2012, National Center for Health Statistics, 1
- Hurd, 2015, Future monetary costs of dementia in the United States under alternative dementia prevalence scenarios, Journal of Population Ageing, 8, 101, 10.1007/s12062-015-9112-4 · DOI · Paper page
- Jagger, 2016, A comparison of health expectancies over two decades in England: Results of the Cognitive Function and Ageing Study I and II, Lancet (London, England), 387, 779, 10.1016/S0140-6736(15)00947-2 · DOI · Paper page
- Knapp, 2014, Scenarios of Dementia Care: What Are the Impacts on Cost and Quality of Life?
- Lakdawalla, 2004, Are the young becoming more disabled, Health Affairs (Project Hope), 23, 168, 10.1377/hlthaff.23.1.168 · DOI · Paper page
- Langa, 2017, A comparison of the prevalence of dementia in the United States in 2000 & 2012, Journal of the American Medical Association Internal Medicine, 177, 51
- Langa, 2005, The aging, demographics, and memory study: Study design and methods, Neuroepidemiology, 25, 181, 10.1159/000087448 · DOI · Paper page
- Matthews, 2005, The incidence of dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study, PLoS Medicine, 2, e193, 10.1371/journal.pmed.0020193 · DOI · Paper page
- Murphy, 2006, The value of health and longevity, Journal of Political Economy, 114, 871, 10.1086/508033 · DOI · Paper page
- Norton, 2014, Potential for primary prevention of Alzheimer’s disease: An analysis of population-based data, The Lancet Neurology, 13, 788, 10.1016/S1474-4422(14)70136-X · DOI · Paper page
- Sieban, 2012, Educational attainment in the US: 2009
- Sloane, 2002, The public health impact of Alzheimer’s disease, 2000-2050: Potential implication of treatment advances, Annual Review of Public Health, 23, 213, 10.1146/annurev.publhealth.23.100901.140525 · DOI · Paper page
- Wilson, 2011, Sources of variability in estimates of the prevalence of Alzheimer’s disease in the United States, 74
- Wolozin, 2007, Simvastatin is associated with a reduced incidence of dementia and Parkinson’s disease, BMC Medicine, 5, 20, 10.1186/1741-7015-5-20 · DOI · Paper page
- Xia, 2017, Association of in vivo [18F]AV-1451 Tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease, JAMA Neurology, 74, 427, 10.1001/jamaneurol.2016.5755 · DOI · Paper page
- Zissimopoulos, 2016, Sex and race differences in the association between statin use and the incidence of Alzheimer disease, JAMA Neurology, 74, 225, 10.1001/jamaneurol.2016.3783 · DOI · Paper page
Cited by
Drabo, E. F., Barthold, D., Joyce, G., Ferido, P., Chang Chui, H., & Zissimopoulos, J. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.005 · Cited by 155
Self-citationChen, Y., Tysinger, B., Crimmins, E., & Zissimopoulos, J. M. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.04.003 · Cited by 129
“To reduce measurement error in dementia ascertainment based on cognitive scores, we required one wave with dementia and evidence of continued cognitive impairment in the next consecutive wave [6,19].”
BackgroundMethodSelf-citationHu, J., Qing, Z., Liu, R., Zhang, X., Lv, P., Wang, M., Wang, Y., He, K., Gao, Y., & Zhang, B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.626154 · Cited by 70
Chen, C., Thunell, J., & Zissimopoulos, J. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12082 · Cited by 45
Self-citationGarcia, M. A., Downer, B., Chiu, C.-T., Saenz, J. L., Ortiz, K., & Wong, R. (2021) · The Gerontologist · doi:10.1093/geront/gnaa112 · Cited by 47
Metadata
- Authors
- Zissimopoulos, J. M., Tysinger, B. C., St.Clair, P. A., & Crimmins, E. M.
- Venue
- The Journals of Gerontology: Series B
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-16
- Volume
- 73
- Issue
- suppl_1
- Pages
- S38-S47
- ISSN
- 1079-5014 (ISSN-L)
- 1758-5368
- OpenAlex
- W2801689578
- Cited by
- 142
- References
- 11
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Institute on Aging (5P30AG024968, P30AG017265, P30AG012846)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer’s Disease and Other Dementias in the United States. https://app.cochat.ai/papers/10.1093/geronb/gbx147
- The paper
- Zissimopoulos, J. M., Tysinger, B. C., St.Clair, P. A., & Crimmins, E. M. (2018). The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer’s Disease and Other Dementias in the United States. The Journals of Gerontology: Series B. https://doi.org/10.1093/geronb/gbx147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.